Biotech News
Charles River Laboratories Announces Third-Quarter 2026 Results
WILMINGTON, Mass. --(BUSINESS WIRE)--Nov. 4, 2026-- Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the third quarter ended September 26, 2026. Key Highlights Reports third-quarter revenue of $982.7 million, GAAP earnings per share of $6.86, and non-GAAP
